Editas Medicine Inc (NASDAQ:EDIT)

31.25
Delayed Data
As of Nov 27
 +1.80 / +6.11%
Today’s Change
14.01
Today|||52-Week Range
39.96
+5.54%
Year-to-Date

Today’s Trading

Previous close29.45
Today’s open29.76
Day’s range29.56 - 31.47
Volume23,784
Average volume (3 months)875,209
Market cap$2.0B
Data as of 3:50pm ET, 11/27/2020

Growth & Valuation

Earnings growth (last year)-14.61%
Earnings growth (this year)+36.98%
Earnings growth (next 5 years)-2.31%
Revenue growth (last year)-35.71%
P/E ratioNM
Price/Sales72.09
Price/Book6.49

Competitors

 Today’s
change
Today’s
% change
DRNADicerna Pharmaceutic...+1.14+4.88%
AUPHAurinia Pharmaceutic...+0.58+4.15%
STOKStoke Therapeutics I...+2.61+5.44%
ATRAAtara Biotherapeutic...+0.24+1.04%
Data as of 12:59pm ET, 11/27/2020

Financials

Next reporting dateMarch 9, 2021
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$20.5M
Annual profit (last year)-$133.7M
Net profit margin-651.43%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts